| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.950 | 0 | 0 | 1987 | 2020 | ||||||||
|
BRCA1 interacting protein C-terminal helicase 1 | 0.507 | 0.731 | 6.2E-17 |
|
disease | 0.700 | None | 0.950 | 0 | 1 | 2003 | 2020 | ||||||||
|
prohibitin | 0.511 | 0.846 | 0.76 |
|
disease | 0.500 | None | 0.944 | 0 | 0 | 1993 | 2018 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.500 | None | 0.934 | 0 | 6 | 1996 | 2020 | ||||||||
|
RAD51 recombinase | 0.447 | 0.846 | 2.7E-02 |
|
disease | 0.500 | None | 0.944 | 0 | 0 | 1997 | 2019 | ||||||||
|
BRCA1 associated RING domain 1 | 0.597 | 0.538 | 1.4E-24 |
|
disease | 0.500 | None | 0.860 | 0 | 0 | 1996 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 4 | 0.455 | 0.846 | 1.00 |
|
disease | 0.500 | None | 1.000 | 0 | 1 | 1995 | 2019 | ||||||||
|
protein phosphatase, Mg2+/Mn2+ dependent 1D | 0.513 | 0.808 | 2.2E-11 |
|
disease | 0.500 | None | 0.960 | 0 | 0 | 2002 | 2020 | ||||||||
|
solute carrier family 22 member 18 | 0.595 | 0.692 | 6.5E-06 |
|
disease | 0.460 | None | 1.000 | 0 | 0 | 1997 | 2018 | ||||||||
|
N-ribosyldihydronicotinamide:quinone reductase 2 | 0.628 | 0.500 | 8.8E-07 |
|
disease | 0.430 | None | 1.000 | 0 | 0 | 2009 | 2011 | ||||||||
|
RAD54 like | 0.633 | 0.423 | 2.4E-15 |
|
disease | 0.420 | None | 0.500 | 0 | 0 | 2017 | 2017 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.400 | None | 0.909 | 0 | 0 | 1992 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.992 | 0 | 0 | 2001 | 2020 | ||||||||
|
GATA binding protein 3 | 0.415 | 0.846 | 0.90 |
|
disease | 0.400 | None | 0.940 | 0 | 0 | 1999 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2007 | 2020 | ||||||||
|
inositol polyphosphate-4-phosphatase type II B | 0.573 | 0.577 | 0.55 |
|
disease | 0.380 | None | 1.000 | 0 | 0 | 2010 | 2017 | ||||||||
|
mitogen-activated protein kinase kinase 4 | 0.559 | 0.692 | 1.00 |
|
disease | 0.360 | None | 1.000 | 0 | 0 | 1998 | 2019 | ||||||||
|
polybromo 1 | 0.566 | 0.615 | 1.00 |
|
disease | 0.340 | None | 1.000 | 0 | 0 | 2005 | 2017 | ||||||||
|
mitogen-activated protein kinase kinase kinase 13 | 0.743 | 0.192 | 0.80 |
|
disease | 0.320 | None | 1.000 | 0 | 0 | 1997 | 2017 | ||||||||
|
Bruton tyrosine kinase | 0.464 | 0.808 | 1.00 |
|
disease | 0.320 | None | 1.000 | 0 | 0 | 2013 | 2016 | ||||||||
|
HECT and RLD domain containing E3 ubiquitin protein ligase 2 | 0.568 | 0.692 | 1.00 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2007 | 2007 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | 0.695 | 0.385 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
AT-rich interaction domain 1B | 0.503 | 0.846 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
partner and localizer of BRCA2 | 0.485 | 0.769 | 3.0E-19 |
|
disease | 0.700 | None | 0.961 | 1 | 4 | 2007 | 2020 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.700 | None | 0.992 | 1 | 0 | 1999 | 2020 |